Status
Conditions
Treatments
About
MOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
The study will involve patients (≥ 6 years of age) from the participating centres treated with Eqwilate® (either on-demand, as perioperative prophylaxis, or as prophylaxis) during the time inclusion period will be opened. Patients will be of any VWD type, previously treated or untreated.
Exclusion criteria
47 participants in 1 patient group
Loading...
Central trial contact
Mikaela Raymond
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal